SCLXbenzinga

Scilex Holding To Present Post-Hoc Analysis Of C.L.E.A.R. Trial On Clinical Meaningfulness Of Safety And Efficacy Of SP-102 For Lumbosacral Radicular Pain At 27th Annual Meeting Of ASIPP

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 1, 2025 by benzinga

    Scilex Holding To Present Post-Hoc Analysis Of C.L.E.A.R. Trial On Clinical Meaningfulness Of Safety And Efficacy Of SP-102 For Lumbosacral Radicular Pain At 27th Annual Meeting Of ASIPP | SCLX Stock News | Candlesense